[en] The aim of this current study was to perform a preliminary clinical assessment of efficacy and safety of a biodegradable gentamicin-loaded monoolein gel. An open single dose, one treatment study including 19 patients with chronic osteomyelitis caused by a microorganism sensitive to gentamicin was conducted. After surgical curettage of the infected bone, the dead space was filled in with the gentamicin-loaded monoolein gel. To prevent post-operative septicaemia, a systemic antibiotherapy was prescribed for 3 days following the operation. Clinical, biological and radiological follow-up was performed to assess the efficacy and the safety of the treatment. After a follow-up period ranging from 2 to 12 months, all 19 patients included in the study felt well. Eighteen patients recovered from chronic osteomyelitis without adverse events. The wound of one patient whose bone was exposed did not scar over after 10 months. However, it was no longer infected. In conclusion, gentamicin-loaded monoolein gel was efficacious in treating chronic osteomyelitis without side-effects.
Disciplines :
Pharmacy, pharmacology & toxicology
Author, co-author :
Ouédraogo, M
Da, C.S
Nacoulma, I.S
Kafando, H
Semde, R
Some, I.T
Ouédraogo, R
Guissou, I.P
Evrard, Brigitte ; Université de Liège - ULiège > Département de pharmacie > Pharmacie galénique
Henschel, V
Dubois, J
Amighi, K
Language :
English
Title :
Preliminary Clinical Assessment of a Gentamicin-Loaded Monoolein Gel Intended to Treat Chronic Osteomyelitis
Blaha, J.D., J.H. Calhoun, C.L. Nelson, S.L. Henry, D. Seligson, J.L. Esterhai, R.B. Heppenstall, J. Mader, R.P. Evans and J. Wilkins, 1993. Comparison of the clinical efficacy and tolerance of gentamicin PMMA beads on surgical wire versus combined and systemic therapy for osteomyelitis. Clin. Orthop., 295: 8-12.
Bucholz, H.V., R.A. Elson, E. Engelbrecht, H. Lodenkamper, J. Rottger and A. Siegel, 1981. Management of deep infection of total hip replacement. J. Bone Joint Surg. (Br.), 63: 342-353.
Elisenber, M., H. Koffer, R.A. Glick, M.L. Comvell, L.E. Loss, G.H. Talbot, N.H. Shusterman and B.L. Strom, 1987. What is the cost of nephrotoxicity associated with aminoglycosides? Ann. Int. Med., 107: 900-909.
Fitzgerald, R.H., P.E. Ruttle, P.G. Arnold, P.J. Kelly and G.B. Irons, 1985. Local muscle flaps in the treatment of chronic osteomyelitis. J. Bone Joint Surg., 67: 175-185.
Ganem-Quintanar, A., D. Quintanar-Guerrero and P. Buri, 2000. Monolein: A review of the pharmaceutical applications. Drug Dev. Ind. Pharm., 26: 809-820.
Garvin, K., B. Evans, E. Salvati and B. Branse, 1994. Palacos gentamicin for the treatment of deep periprosthetic hip infection. Clin. Orthop., 298: 97-105.
Hall, B.B., R.H. Fitzgerald and J.E. Rosenblatt, 1983. Anaerobic osteomyelitis. J. Bone Joint Surg., 65: 30-35.
Kanellakopoulou, K. and E.J. Giamarellos-Bourboulis, 2000. Carrier systems for the local delivery of antibiotics in bone infections. Drugs, 59: 1223-1232.
Klemm, K. W., 1993. Antibiotics beads chains. Clin. Orthop., 295: 63-76.
Langlais, F., L. Bunetel, A. Segui, N. Sassi and M. Cormier, 1988. Ciments orthopédiques aux antibiotiques. Pharmacocinétique et taux osseux. Rev. Chir. Orthop., 74: 493-503.
Lew, D.P. and F.A. Waldvogel, 1997. Current concepts, osteomyelitis. N. Engl. J. Med., 336: 999-1007.
Mauduit, J., N. Brukh and M. Vert, 1993. Gentamycin/poly(lactic acid) blends aimed at sustained release local antibiotic therapy administered per-operatively. I. The case of gentamycin base and gentamycin sulfate in poly(D, L-lactic acid) oligomers. J. Control Rel., 23: 209-220.
Méani, E. and C. Romano, 1994. Traitement de l'ostéomyélite par antibiothérapie locale utilisant une micropompe électronique portable. Rev. Chir. Orthop., 80: 285-290.
Mendel, V., H.J. Sirnanowski, H.C. Scholz and H. Heymann, 2005. Therapy with gentamicin-PMMA beads, gentamicin-collagen sponge and cefazolin for experimental osteomyelitis due to Staphylococcus aureus in rats. Arch. Orthop. Trauma Surg., 125: 363-368.
Miclau, T., E. Dahners and R.W. Lindsey, 1993. In vitro pharmacokinetics of antibiotics release from locally implantable materials. J. Orthop. Res., 11: 627-632.
Nacoulma, S.I., D.D. Ouedraogo, E.W.C. Nacoulma, A. Korsaga and J.Y. Drabo, 2007. Chronic osteomyelitis in University Hospital of Ouagadougou (Burkina Faso). Retrospective study of 102 cases/Ostéomyélites chroniques au CHU de Ouagadougou (Burkina Faso). Etude retrospective de 102 cas (1996-2000). Bull. Soc. Pathol. Exot., 100: 264-268.
Nelson, C.L., R.P. Evans, J.D. Blaha, J. Calhoun, S.L. Henry and M.J. Patzakis, 1993. A comparison of gentamicin-irnpregnated polymethylmethacrylate bead implantation to conventional parenteral antibiotic therapy in infected total hip and knee arthroplasty. Clin. Orthop., 295: 96-101.
Parsons, B. and E. Strauss, 2004. Surgical management of chronic osteomyelitis. Am. J. Surg., 188: 57-66.
Rowe, R.C., P.J. Sheskey and P.J. Weller, 2003. Handbook of Pharmaceutical Excipient. 4th Edn. The Pharmaceuticals Society of Great Britain and the American Pharmaceutical Association, Washington London.
Schmidt, C., R. Wenz, B. Nies and F. Moll, 1995. Antibiotic in vivo!in vitro release, histocompatibility and biodegradation of gentamicin implants based on lactic acid polymers and copolymers. J. Control Rel., 37: 83-94.
Sivakuma, M. and K.P. Rao, 2002. In vitro release of ibuprofen and gentamicin from PMMA functional microspheres. J. Biomater. Sci. Polyrn. Edn., 13: 111-126.
Springer, I.N.G., J. Wiltfang, A. Dunsche, G.C. Lier, M. Bartsch, P.H. Warnke, A. Barth, H. Terheyden, P.A.J. Russo, N. Czech and Y. Acil, 2007. A new method of monitoring osteomyelitis. Int. J. Oral Maxillofac. Surg., 36: 527-532.
Waldvogel, F.A., G. Medoff and M. Swartz, 1970. Osteomyelitis: A review of clinical features, therapeutic considerations and unusual aspects. New Eng. J. Med., 282: 198-206.
